Press Release: Availability of the revised financial statements for Sanofi excluding Opella
Availability of the revised financial statements for Sanofi excluding OpellaParis, France – December 6, 2024. Following the press release on ...
pharmaphorum1mon
France warns of penalties if Opella production goes offshore
Sanofi is now in exclusive talks with private equity company Clayton Dubilier & Rice over the sale of a controlling stake in its consumer health business Opella, as the French government seeks to ...
MarketWatch1mon
PAI Partners Submits Improved Bid on Sanofi's Consumer Unit
PAI partners submitted an improved bid for Sanofi's consumer health business, in an attempt to reenter the race for what could be one of the pharma industry's biggest deals this year. The French ...
pharmaphorum2mon
Sanofi in talks to sell stake in consumer health spinout
Rumours that Sanofi was in discussion with private equity groups over the sale of its consumer health business Opella have been confirmed – at least partially. The French pharma group confirmed ...
PharmiWeb6d
Availability of the revised financial statements for Sanofi excluding Opella
Following the press release on October 21, 2024 and the plan to transfer a 50% controlling stake in Opella (consumer healthcare division) to CD&R, the revised financial statements for Sanofi ...